Through the suppression of miRNAs targeting various TME signaling, tumor cells together with CAFs and TAMs orchestrated KRAS induced tumor promotion, ECM remodeling, epithelial-mesenchymal transition as well as immunosuppression in PDAC TME, which favors tumor promotion. The gene discussed is KRAS; the disease is neoplasm.